Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20190604Phase 3Completed
A Phase 3 trial of Jiuwei Xifeng Granules in tic disorder, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20190604.